New Zealand markets open in 7 hours 52 minutes

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
6.63+0.01 (+0.15%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
676,855
671,627
654,973
693,965
758,132
Cost of revenue
233,819
240,598
206,815
202,120
198,278
Gross profit
443,036
431,029
448,158
491,845
559,854
Operating expenses
Research development
50,650
47,144
44,304
39,715
31,794
Selling general and administrative
175,096
168,096
204,108
219,815
288,661
Total operating expenses
304,690
294,244
312,165
327,134
374,718
Operating income or loss
138,346
136,785
135,992
164,711
185,135
Interest expense
15,173
15,261
9,133
4,521
4,960
Income before tax
169,755
174,062
163,841
197,503
188,894
Income tax expense
14,597
12,012
2,659
26,275
23,943
Income from continuing operations
155,158
162,050
161,182
171,228
164,951
Net income
155,832
162,897
161,583
170,797
165,144
Net income available to common shareholders
155,832
162,897
161,583
170,797
165,144
Basic EPS
0.53
0.50
0.49
0.52
0.51
Diluted EPS
0.53
0.50
0.49
0.52
0.51
Basic average shares
323,961
325,793
329,762
327,556
325,636
Diluted average shares
323,961
325,793
329,762
327,556
325,636